The effects of time-delay on feedback control of depth of anesthesia by Abdulla, Shahab A. & Wen, Peng
  
 
Abstract— This paper presents a new procedure to find the 
impact of the time-delay (TD) of the patient and 
instrumentations such as bispectral index (BIS) monitor on 
closed-loop control of depth of anaesthesia during surgery. In 
the current work, the TD is estimated using Smith Predictive 
control technique. The method is validated with measured BIS 
signals in simulation. The results showed that the proposed 
procedure improves the performance of the closed-loop system 
for reference tracking and overall stability, and the proposed 
method has less overshoot, shorter settling time and is more 
robust to disturbances. 
I. INTRODUCTION 
EDICAL Medical experience with critically ill Medical 
experience with critically ill patients has revealed that 
standard dosing guidelines often result in an inappropriate 
under- or over-sedation which is leading to increased 
mortality due to huge inter-patient pharmacological 
variability [1], [2], [3].Open-loop control (manual control) 
by clinical personnel can be tedious, imprecise, time-
consuming, and sometimes of poor quality. Hence, the need 
for active control (closed-loop control) in medical systems is 
significant, with the potential for improving the quality of 
medical care as well as curtailing the increasing cost of 
health care. During anaesthesia there is a time delay between 
the administration of the drug and the start of mixing in the 
central nerve system, estimation of the time delay is an 
important issue to closed loop control in surgery theatre [4], 
[5].  
The Pharmacokinetic (PK) time delay is consistent for each 
individual patient, but can vary significantly between 
different patients. The origin of the time-delay (TD) is the 
period of time from the start of infusion pump until the drug 
is distributed along the central nerve system; the TD varies 
from one time instant to another, dependent on the signal 
quality. If not dealt-with appropriately, such varying TD are 
a source of poor feedback control [6].   This  system is 
modeled as the  open  loop   transfer  function   followed  by  
a time  delay represented using a  1
st  
 order  Pade  
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approximation. The Pade approximants is used to 
approximate functions by rational functions [7]. A controller 
design technique is proposed based on a delay-dependent 
approach. The aim of this study is to establish and validate a 
TD estimation method using Smith Predictive to overcome 
the lack of TD information in online clinical trials for 
closed-loop sedation in surgery. To estimate the time-delay, 
some researchers have used the concept of the cross-
correlation analysis, which is defined as estimation of the 
time-delay originated from instrumentation only (BIS 
monitor) during intensive care period  [2] and, the estimated 
time-delay is then used in the prediction model of the 
extended prediction self-adaptive control algorithm 
(EPSAC).  
 
The paper is organized as follows:  Section 2 introduces 
human body model for DoA.  Section 3 describes materials 
and methods, Section 4 describes Smith technique and 
Section 5 provides simulation and results. The conclusions 
are drawn in Section 6.  
II. HUMAN BODY MODEL FOR DEPTH OF ANAESTHESIA 
CONTROL 
The  patient  body  is  divided  into  several  
compartments  to  drive  the  pharmacokinetic  (PK)  model 
[8]. In each compartment, the drug concentration is 
homogeneous as shown in Fig. 1. A three-compartment 
model is used, in which the main compartment represents 
intravascular blood (blood within arteries and veins) and 
highly irrigated organs (such as heart, brain, liver and 
kidney). The other two compartments represent muscles, fat, 
and other organs or tissues.  
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Fig. 1.   PK compartments model. 
 
The PK model provides the propofol plasma concentration 
from a given dose of propofol injected to the patient.  
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where PK is expressed as: 
      
     
    
  
 
    
  
 
    
  
 
    
                                                       
where          is  the  drug  concentration  expressed  in  
microgram  per  milliliter  (propofol),            in the 
above formula would refer to the rate  constant  of the  
distribution phase and    is  the  rate  constant  of the  
elimination phase.  
where       is the control input.  
 
PD is expressed as: 
      
   
     
 
 
     
                                                           
where     is the inverse of the effect-site compartment 
time constant and      is the half-maximal effective 
concentration. 
The Hill curve is represented by the following equation: 
 
                
  
    
  
         
                                         
   denotes  the  baseline  value  (awake  state)  and  by  
convention  a  value  of  100  is  assigned.       denotes the 
maximum  effect  achieved  by  the  drug.      is the  drug 
effect-site  concentration,       is  the  drug  concentration  
at half maximum effect and represents the patient sensitivity 
to the drug, and γ   determines the steepness of the curve.   
The patient’s PK and PD models are used to predict the 
BIS output as a result of drug infusion. The generalized PK–
PD model for propofol is shown in Fig. 2.  
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Fig. 2.    DoA model 
III. MATERIALS AND METHODS 
The total time delay can be categorized into two parts. 
The first is related to the instrumentation parts, representing 
the time delays at the instrument devices and the second are 
related to the dynamic response of the patient (non-
instrumentation delay).  
A. Time-Delay estimation 
During surgery, when the patient arrives at the ICU, the 
desired BIS target is 50 and must remain between 40 and 60 
for a good sedation level. At around 50 BIS can be 
approximated linearly by a line, using this relation, as in 
 
                                                                                    
 
where    represents  the  slope  of  the  linear  
approximation and     is  a  constant. 
The real values of the parameters for the selected 12 
patient sets are given in Table 1 have been taken form 
reference [1] and simulated BIS signals were obtained based 
on the scheme presented in Fig. 3. The Propofol infusion is 
applied to the patient and the real BIS signal is recorded by 
the BIS monitor.  As mentioned above, the monitor 
introduces a time-delay. The same Propofol infusion rate is 
used in the simulator to obtain the simulated BIS signal. 
Using the PK-PD patient model, the effective concentration 
of the drug is calculated. The  simulated  BIS  signal  is  
related  to  the  effective concentration  of  the  drug  by  the  
Hill  curve.  A delay is added to simulate the delay 
introduced by the real monitor. 
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Fig. 3.   The representation of the real and simulated BIS 
 
With the time-delay introduced by the BIS monitor, the 
real BIS signal can be expressed by the following relation, as 
in 
 
                                                                        
 
SPC is a solution for controlling processes that present 
significant and varying dead times is to make use of a dead-
time compensator (delays at the instruments). SPC provides 
a control strategy for linear processes with variable TD. The 
method of SPC was the first control system strategy 
proposed in the literature that included a dead-time 
compensator, and SPC is one of the most widely used 
methods to compensate the variable TD problem. 
B. Identifying the PK time-delay 
Inter-patient   variability clearly plays a prominent role in 
the overall system uncertainty [9].  For  instance, there is a 
significant difference  in the PK  time  delay  and  PD  time  
constant  between  patients.   Also,  while the  EC50  
variability is more  limited,  there is still  a 6-times  
difference  in terms  of the  overall  PK-PD   steady state  
gain [9]. The PD   identification during induction, however, 
may not be practical due to a large number of factors that 
  
can affect the anaesthesia time course [9].   
One advantage of the SPC structure in case the PK time 
delay is known, is that there is no longer a need for a distinct 
controller for each patient. As far as the implementation of 
the SPC is concerned, the nominal time delay is now 
replaced by the identified time delay. 
IV. SMITH PREDICTOR CONTROLLER FOR DEPTH OF 
ANAESTHESIA 
The Smith  predictor  controller is  able  to  compensate  
for  the  dead time,  through  the  use  of  a mathematical 
model of the process and its dead-time to feedback to the 
primary controller, what the process variable would have 
behaved  without  the  delay. In addition, the performance of 
the SPC largely depends on the accuracy of the process 
model. 
In   systems  with  large  delays,  performance  can  also  
be  improved by  using a  Smith Predictor  Controller 
structure  that  compensates  for  the  nominal time  delay.  
This time delay compensation allows an increase in the 
controller bandwidth, which results in improved 
performance. 
The  Smith  Predictor makes  use  of  the  nominal  model  
of  the  system  in  order  to  compensate   for the  delay. The  
zero-delay  nominal  model  is  simulated  based  on  the  
same  infusion  rate that  is input  to  the  system.  As such,  
the  model  output  represents  the  predicted  delay-free  
response  of  the system.   This response is then compared to 
the response with delay.   The result of this comparison is a 
signal that represents the future system response to the 
control action.  This signal is then added to the feedback 
signal.  As a result, the controller can be designed based  on 
a delay-free model,  which  results in added  stability in the 
control loop  that  can be further  used  to increase  the 
controller  bandwidth.   While the  inherent  limitation  of a 
delayed system  is still  present,  the increased  control 
bandwidth  usually  results in   increased  performances. 
 
The SPC proposed a control structure to compensate for 
the delay time shown in Fig. 4. By using  this  structure,  the  
effect  of  the  delay  time  in  the system can be properly 
removed. As shown in Figure 6,       is   the   controller,   
the       denotes the transfer function  of  the  patient  
without  delay  time  and        is the estimation model of 
the system,    is the delay time of the patient, and     is the 
delay time of measurement. The transfer function is obtained 
in the following equation:  
 
    
    
                                                                                                
 
           
    
                          
                      
 
 
In Fig. 4, the part of with the dotted line is the SPC and its 
transfer function obtained below: 
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Fig. 4. The control structure with the Smith predictor 
 
      
     
                       
                                       
 
When              and         and then equation (2) 
is become:  
 
     
    
    
  
          
            
                                          
 
where        is the patient model and consist of two parts, 
PK and PD [1]. 
Thus, the system will present the same closed-loop 
performance without the time delay, only with the pure input 
time delay   .  The Smith predictor Controller is purposed 
when DoA delays are significant as   =   . 
V. SIMULATION AND RESULTS 
The study was performed on a data set of 12 patients from  
[1]. The parameters of nominal patient obtained for the 
pharmacokinetics model were          ,          ,  
         ,            ,           ,          , 
         ,      , as shown in Table 1. The adjustment 
of the controller gains was made in a simulation way trying 
to get a smooth transitory and a stable response. For  
validation  purpose,  a  representation  of  the  real  BIS 
signal    “signal without time-delay”  was  built. A  time-
delay  was added  to  the  simulator  in  order  to  represent  
the  delay introduced  by  the  BIS  monitor.  Thus, after 
several trials adequate values for SP controller set values 
was tested in the whole population of the study with 
satisfactory results. Fig. 5 and 6 presents the evolution of the 
anaesthesia for three different patients. The controller 
parameters are adjusted depending on  the  error  between  
the  system  output  (BIS)  and  the model  reference  output  
defined  for  this  closed-loop.  
 
The delay signal is then added to the feedback signal.  As  
a  result,  the controller based  on a delay-free  model,  
which  results in added  stability in the control loop  that  can 
be further  used  to increase  the controller  bandwidth.   
While the  inherent  limitation  of a delayed system  is still  
present,  the increased  control bandwidth  usually  results in   
improved  performances. As far as the implementation of the 
SPC is concerned, the nominal time delay is now replaced 
by the identified time delay. 
  
When a patient has significant time delay, it is quite 
common to augment the controller with a Smith predictor, a 
construction that removes the delay term from the 
characteristics polynomial of the closed loop. 
 
TABLE 1 VALUES OF THE PARAMETERS FOR THE 12 PATIENTS SETS 
ARRANGED IN THE DECREASING ORDER OF THEIR BIS SENSITIVITY TO 
PROPOFOL INFUSION 
Parameter 
Patient no. k10 k12 k21 k13 k31 ke0 EC50 γ 
 (sensitive)        
1 0.08925 0.084 0.06875 0.031425 0.004125 0.459 1.6 2 
2 0.14875 0.14 0.04125 0.052375 0.004125 0.239 1.6 2 
3 0.14875 0.112 0.04125 0.0419 0.004125 0.239 1.6 3.133 
4 0.14875 0.14 0.04125 0.052375 0.004125 0.239 1.6 3.133 
5 0.08925 0.084 0.04125 0.052375 0.002475 0.459 2.65 2.551 
6 0.14875 0.112 0.06875 0.031425 0.002475 0.459 2.65 2.551 
(nominal)       
7 0.119 0.112 0.055 0.0419 0.0033 0.349 2.65 2.551 
8 0.119 0.112 0.055 0.0419 0.0033 0.239 2.65 2 
9 0.119 0.112 0.055 0.0419 0.0033 0.349 2.65 2.551 
10 0.08925 0.084 0.06875 0.031425 0.002475 0.459 3.7 2 
11 0.14875 0.112 0.06875 0.031425 0.002475 0.349 3.7 2.551 
(insensitive)   
12 0.08925 0.084 0.04125 0.052375 0.002475 0.239 3.7 3.133 
          
Fig. 5. Smith predictor with nominated TD 
Fig. 6. Smith predictor with TD for 3 patients 
VI. CONCLUSIONS 
In this paper, the Smith Predictive Control has been 
introduced to estimate the TD originated from the patient 
and instrumentation (BIS monitor). The TD estimation 
algorithm is tested on a data set of 12 patients. The obtained 
results agree to similar studies reported in literature.  
The estimation algorithms are based on the Smith 
Predictive Control. The improved time-delay compensation 
modules notably improve the performance of the overall 
patient response. These models have been implemented 
using Simulink and Matlab Control Toolbox and evaluated 
in simulation. The results have been compared to the control 
without time delay compensator. In the proposed system, the 
settling time has been shorten about 30% and the over and 
undershoot has been reduced about 15%.  
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